Dr. Ariana Smith

this lifting of the warning will translate to more prescriptions and more filling and more refilling of these prescriptions.

And maybe we'll start hearing about estrogen instead of vaginal rejuvenation.

I'm seeing a variety of practices in the Philadelphia area.

I think most commonly I see the OBGYNs prescribing standard menopausal hormonal therapy to postmenopausal women.

But I do see a lot of women who are going out to seek

more comprehensive care, holistic care.

There's a lot of different terms being used.

And a lot of them are specifically seeking compounded therapies.

And I will see incorporation of testosterone into these therapies.

And I've heard women, when I've asked them specifically about how their combination of medications has been determined, they'll say, oh, I spoke to my provider about weight gain.

And they thought the testosterone could help me with my weight gain.

Or I've talked to my provider about interest in sexual activity.

And they told me maybe the testosterone could help me there.

I think maybe we don't really know.

But to Karen's point, I don't think there's a lot of evidence to support the practice.

And it would be a great area for really additional studies to try to understand if there is a role for some of these more challenging to treat components of menopause.

Yeah.

In that same vein, you know, as urologists, we are operating in the space of the gynecologic organs.

We're often performing hysterectomies, oophorectomies, salpingectomies, but we aren't having those conversations with women about menopausal hormonal support after we remove those organs.

I mean, this is really common among our urologic oncologists who are working in this space.